Capital Power Co. (TSE:CPX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twelve research firms that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is C$68.78.
CPX has been the topic of a number of recent analyst reports. National Bankshares raised their target price on shares of Capital Power from C$64.00 to C$66.00 and gave the stock an “outperform” rating in a research note on Friday, September 19th. Desjardins boosted their price target on shares of Capital Power from C$75.00 to C$80.00 and gave the stock a “buy” rating in a research report on Friday, September 19th. CIBC boosted their price target on shares of Capital Power from C$66.00 to C$72.00 in a research report on Thursday, July 10th. Scotiabank boosted their price objective on shares of Capital Power from C$67.00 to C$70.00 and gave the company an “outperform” rating in a research report on Friday, September 19th. Finally, Royal Bank Of Canada upgraded shares of Capital Power from a “sector perform” rating to an “outperform” rating and boosted their price objective for the company from C$65.00 to C$67.00 in a research report on Thursday, July 31st.
Get Our Latest Research Report on Capital Power
Capital Power Stock Performance
Capital Power Company Profile
Capital Power Corp is a North American power producer whose principal activities are developing, acquiring, and operating power plants. Through its subsidiary, Capital Power owns and operates a portfolio of natural gas, coal, wind, solar, and solid fuel energy generating facilities. These are located throughout Western and Central Canada and the U.S.
Featured Stories
- Five stocks we like better than Capital Power
- Stock Average Calculator
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What is MarketRank™? How to Use it
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Capital Power Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capital Power and related companies with MarketBeat.com's FREE daily email newsletter.